Sustainability of antiemetic responses with APF530 (sustained-release granisetron) during multiple cycles of moderately (MEC) and highly (HEC) emetogenic chemotherapy regimens: Results of a randomized phase III trial.
Ralph V. Boccia
No relevant relationships to disclose
William Cooper
Employment or Leadership Position - Beardsworth Consulting Group
Erin O'Boyle
Employment or Leadership Position - A.P. Pharma
Stock Ownership - A.P. Pharma